+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vertebroplasty - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302169
The global market for Vertebroplasty was estimated at US$287.5 Million in 2023 and is projected to reach US$426.7 Million by 2030, growing at a CAGR of 5.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Vertebroplasty Market - Key Trends and Drivers Summarized

What Is Vertebroplasty and How Does It Work?

Vertebroplasty is a cutting-edge, minimally invasive surgical procedure developed to treat painful vertebral compression fractures (VCFs) caused primarily by osteoporosis, metastatic cancers, or trauma. This procedure entails injecting a specialized acrylic bone cement, most commonly polymethylmethacrylate (PMMA), directly into the fractured vertebra to stabilize it and provide rapid pain relief. During vertebroplasty, the surgeon carefully inserts a thin needle through the skin into the fractured bone under continuous real-time fluoroscopic or CT imaging guidance to ensure precise placement of the cement. The cement is injected in a semi-liquid state and quickly hardens inside the vertebra, effectively restoring its structural integrity and reducing micromovements that are the source of pain. What makes vertebroplasty especially appealing is its ability to provide immediate and lasting pain relief, allowing patients to resume normal activities shortly after the procedure. It is typically recommended for patients who have not responded to conservative management, such as bed rest, pain medication, and bracing, making it a critical option for improving the quality of life in individuals with debilitating spinal fractures. Additionally, vertebroplasty has a well-established safety profile, and recent advancements in imaging techniques, cement composition, and procedural methodologies have significantly reduced the associated risks, making it a widely accepted therapeutic option in the orthopedic and neurosurgical communities.

What Are the Major Benefits and Challenges of Vertebroplasty?

The advantages of vertebroplasty are multifaceted, providing substantial clinical benefits to patients with vertebral compression fractures, yet the procedure is not without its challenges. One of its primary benefits is the rapid and significant reduction of pain, which often occurs within hours post-procedure, enabling patients to regain mobility and return to their daily routines much faster than traditional open surgical treatments. This accelerated recovery is particularly crucial for elderly patients with limited physical capacity and those who suffer from multiple comorbidities that complicate their treatment. Furthermore, by stabilizing the fractured vertebra, vertebroplasty prevents further collapse and deformation of the spine, reducing the risk of progressive kyphosis, commonly known as a 'dowager's hump.' Despite these benefits, vertebroplasty has sparked considerable debate in the medical community, primarily due to concerns regarding cement leakage - a complication that occurs when the injected material extrudes from the vertebral body into adjacent structures, potentially causing nerve root compression, embolism, or spinal cord injury. To mitigate these risks, there have been advancements in cement formulations, including the use of higher viscosity cements and refined injection techniques that allow for better control during the procedure. Another significant challenge lies in the selection of appropriate candidates for vertebroplasty, as its efficacy varies depending on the underlying cause of the fracture. While it has shown excellent outcomes in treating osteoporotic fractures, its effectiveness in fractures caused by malignant lesions or high-impact trauma remains a subject of ongoing research, highlighting the need for precise patient evaluation and individualized treatment planning.

How Does Vertebroplasty Compare to Other Treatment Options?

Vertebroplasty stands out as a preferred treatment for certain types of vertebral compression fractures due to its unique benefits, but it is often compared to other procedures like kyphoplasty and spinal fusion, each of which has its own strengths and limitations. Kyphoplasty, a related procedure, involves the use of a balloon tamp to create a cavity within the vertebra before cement is injected, which helps to restore some of the lost vertebral height and correct spinal deformity. While kyphoplasty is more effective in reducing spinal curvature and preventing postural abnormalities, it is typically more expensive and time-consuming than vertebroplasty. Vertebroplasty, by contrast, involves direct cement injection, making it simpler, faster, and less costly. Spinal fusion, a more invasive surgical option, is usually reserved for severe cases involving multiple vertebrae or when there is significant spinal instability. This procedure involves placing bone grafts and metallic hardware to permanently join two or more vertebrae, which increases the complexity, recovery time, and the potential for complications. Due to its minimally invasive nature, vertebroplasty is performed under local anesthesia and often as an outpatient procedure, making it an ideal choice for elderly or medically fragile patients who cannot tolerate the prolonged anesthesia or hospitalization required for more invasive surgeries. Moreover, vertebroplasty's success rate in alleviating pain and stabilizing the fracture is comparable to or even exceeds that of more invasive techniques, making it a highly favorable option, especially when quick pain relief and a return to normal function are primary treatment goals. However, the choice between these options depends on various factors such as the degree of vertebral collapse, overall bone health, and patient-specific preferences following a thorough discussion of the risks and benefits of each treatment modality.

What Are the Market Dynamics Shaping Vertebroplasty Growth?

The growth in the vertebroplasty market is driven by several factors, including the rising prevalence of osteoporosis and related vertebral fractures, advancements in procedural technology, and shifting patient preferences towards less invasive treatment options. The global aging population is a key driver of demand for vertebroplasty, as osteoporosis is particularly prevalent among older adults, especially postmenopausal women, leading to a surge in the number of patients requiring treatment for vertebral compression fractures. Furthermore, the introduction of innovative cement formulations, such as bioactive and radiopaque cements, has improved procedural safety and outcomes, making vertebroplasty a more attractive option for both patients and healthcare providers. Additionally, improvements in imaging techniques, including the adoption of high-definition fluoroscopy and real-time 3D imaging, have enhanced procedural precision, reducing the risk of complications and cement leakage. The growing preference for outpatient and ambulatory surgical settings has also contributed to the market expansion, as vertebroplasty can often be performed without the need for prolonged hospitalization, thereby reducing overall healthcare costs and increasing patient satisfaction. Consumer behavior trends indicate a rising demand for treatments that offer rapid recovery and minimal disruption to daily life, further fueling the adoption of vertebroplasty. Increased awareness among healthcare professionals and patients about the benefits of early intervention for spinal fractures has led to more proactive treatment strategies, expanding the potential patient base. Furthermore, the entry of new market players and strategic partnerships among key stakeholders are expected to boost competition, foster innovation, and drive down costs, making vertebroplasty more accessible. As a result, the vertebroplasty market is poised for robust growth in the coming years, supported by a combination of demographic trends, technological innovations, and evolving patient and provider preferences.

Regional Analysis

Gain insights into the U.S. market, estimated at $76.3 Million in 2023, and China, forecasted to grow at an impressive 8.5% CAGR to reach $95.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Alphatec Spine, Inc., DePuy Synthes (Johnson & Johnson), Globus Medical, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Questions Answered:

  • How is the Global Vertebroplasty Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Vertebroplasty Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vertebroplasty Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Select Competitors (Total 42 Featured):

  • Alphatec Spine, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS (BMK Global Medical Company)
  • Stryker Corporation
  • Zavation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Vertebroplasty - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Prevalence of Spinal Compression Fractures Accelerates Vertebroplasty Adoption
  • Rising Geriatric Population Spurs Demand for Vertebroplasty Procedures
  • Increased Awareness of Minimally Invasive Spine Treatments Expands Market Opportunities
  • Advancements in Imaging Technology Drive Adoption of Precision-Guided Vertebroplasty
  • Shift Towards Minimally Invasive Techniques Over Traditional Open Surgeries Fuels Market Growth
  • Increasing Focus on Outpatient Settings Expands Market Reach for Vertebroplasty Services
  • Innovations in Bioactive Bone Cements Generate New Product Demand
  • Growing Popularity of Personalized, Patient-Specific Solutions Propels Market Expansion
  • Heightened Need for Effective Pain Management in Oncology Patients Increases Vertebroplasty Utilization
  • Wider Physician Training Programs Enhance Market Penetration of Vertebroplasty Procedures
  • Patient Preference for Shorter Recovery Time and Minimally Invasive Options Drives Adoption
  • Surging Healthcare Investments in Emerging Markets Open New Growth Opportunities
  • High Costs and Risk of Procedure-Related Complications Present Market Challenges
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Vertebroplasty Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 5: USA Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 6: USA Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
CANADA
  • Table 7: Canada Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 8: Canada Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
JAPAN
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 9: Japan Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 10: Japan Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
CHINA
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 11: China Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 12: China Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
EUROPE
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 13: Europe Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: Europe Historic Review for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: Europe 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 16: France Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 17: France Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
GERMANY
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 18: Germany Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 19: Germany Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ITALY
  • Table 20: Italy Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: Italy Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
UNITED KINGDOM
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 22: UK Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 23: UK Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SPAIN
  • Table 24: Spain Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 25: Spain Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
RUSSIA
  • Table 26: Russia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: Russia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF EUROPE
  • Table 28: Rest of Europe Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 29: Rest of Europe Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ASIA-PACIFIC
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 30: Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 31: Asia-Pacific Historic Review for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 32: Asia-Pacific 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • Table 33: Australia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 34: Australia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
INDIA
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Table 35: India Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: India Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SOUTH KOREA
  • Table 37: South Korea Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 38: South Korea Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF ASIA-PACIFIC
  • Table 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 40: Rest of Asia-Pacific Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
LATIN AMERICA
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • Table 41: Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 42: Latin America Historic Review for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Latin America 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
  • Table 44: Argentina Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Argentina Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
BRAZIL
  • Table 46: Brazil Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: Brazil Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
MEXICO
  • Table 48: Mexico Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: Mexico Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF LATIN AMERICA
  • Table 50: Rest of Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Latin America Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
MIDDLE EAST
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • Table 52: Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 53: Middle East Historic Review for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 54: Middle East 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
  • Table 55: Iran Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 56: Iran Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
ISRAEL
  • Table 57: Israel Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 58: Israel Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
SAUDI ARABIA
  • Table 59: Saudi Arabia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Saudi Arabia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
UNITED ARAB EMIRATES
  • Table 61: UAE Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 62: UAE Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
REST OF MIDDLE EAST
  • Table 63: Rest of Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 64: Rest of Middle East Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
AFRICA
  • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • Table 65: Africa Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: Africa Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alphatec Spine, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS (BMK Global Medical Company)
  • Stryker Corporation
  • Zavation

Table Information